Thyroid hypoplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:95720OMIM:218700E03.1
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thyroid hypoplasia (also known as thyroid gland hypoplasia) is a congenital condition in which the thyroid gland is abnormally small or underdeveloped, resulting in reduced production of thyroid hormones (hypothyroidism). It is classified as a form of thyroid dysgenesis, a group of developmental abnormalities of the thyroid gland that collectively represent the most common cause of congenital hypothyroidism. The thyroid gland, located in the front of the neck, produces hormones (T3 and T4) that are essential for normal growth, brain development, and metabolism. In affected individuals, the underdeveloped thyroid gland cannot produce sufficient thyroid hormones, leading to congenital hypothyroidism. If untreated, this can cause severe intellectual disability, growth failure, delayed skeletal maturation, constipation, feeding difficulties, prolonged neonatal jaundice, hypotonia (decreased muscle tone), a large fontanelle, macroglossia (enlarged tongue), dry skin, and lethargy. The condition primarily affects the endocrine system but has widespread consequences on the nervous system, musculoskeletal system, and overall metabolism due to the critical role of thyroid hormones in development. Thyroid hypoplasia is typically detected through newborn screening programs that measure thyroid-stimulating hormone (TSH) and/or T4 levels. Diagnosis is confirmed by thyroid ultrasound or scintigraphy, which reveals a small but normally located thyroid gland. Treatment consists of lifelong thyroid hormone replacement therapy with levothyroxine (synthetic T4), which should be initiated as early as possible — ideally within the first two weeks of life — to prevent irreversible neurodevelopmental damage. With early diagnosis and appropriate treatment, children with thyroid hypoplasia can achieve normal growth and cognitive development. Some cases are associated with mutations in genes involved in thyroid development, including PAX8, NKX2-1 (TITF1), FOXE1, and TSH receptor (TSHR) genes, though many cases are sporadic with no identifiable genetic cause.

Clinical phenotype terms— hover any for plain English:

Thyroid hypoplasiaHP:0005990
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Thyroid hypoplasia.

View clinical trials →

No actively recruiting trials found for Thyroid hypoplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Thyroid hypoplasia community →

No specialists are currently listed for Thyroid hypoplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Thyroid hypoplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Thyroid hypoplasiaForum →

No community posts yet. Be the first to share your experience with Thyroid hypoplasia.

Start the conversation →

Latest news about Thyroid hypoplasia

No recent news articles for Thyroid hypoplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Thyroid hypoplasia

What is Thyroid hypoplasia?

Thyroid hypoplasia (also known as thyroid gland hypoplasia) is a congenital condition in which the thyroid gland is abnormally small or underdeveloped, resulting in reduced production of thyroid hormones (hypothyroidism). It is classified as a form of thyroid dysgenesis, a group of developmental abnormalities of the thyroid gland that collectively represent the most common cause of congenital hypothyroidism. The thyroid gland, located in the front of the neck, produces hormones (T3 and T4) that are essential for normal growth, brain development, and metabolism. In affected individuals, the un

At what age does Thyroid hypoplasia typically begin?

Typical onset of Thyroid hypoplasia is neonatal. Age of onset can vary across affected individuals.